1. Is the Development of Antibodies to Streptokinase Clinically Relevant?

   • Maurice B. Buchalter

   Leading Article 11 December 2012 Pages: 133 - 136

2. The Clinical Potential of Ademetionine (S-Adenosylmethionine) in Neurological Disorders

   • T. Bottiglieri
   • Keith Hyland
   • Edward H. Reynolds

   Review Article 11 December 2012 Pages: 137 - 152

3. New Anticonvulsant Drugs

   • Martina Bebin
   • Thomas P. Bleck

   Review Article 11 December 2012 Pages: 153 - 171

4. Optimum Outpatient Therapy of Skin and Skin Structure Infections

   • Diane M. Failla
   • George A. Pankey

   Practical Therapeutics 11 December 2012 Pages: 172 - 178

5. Management of Toxoplasmosis

   • St Vassil Georgiev

   Practical Therapeutics 11 December 2012 Pages: 179 - 188

6. Pharmacological Management of Back Pain Syndromes

   • R. W. Porter
   • Stuart H. Ralston

   Practical Therapeutics 11 December 2012 Pages: 189 - 198

7. Foscarnet

   • Antona J. Wagstaff
   • Harriet M. Bryson

   Drug Evaluation 11 December 2012 Pages: 199 - 226

8. Quinapril

   • Greg L. Plosker
   • Eugene M. Sorkin

   Drug Evaluation 11 December 2012 Pages: 227 - 252

9. Risperidone

   • Susan Grant
   • A. Fitton

   Drug Evaluation 11 December 2012 Pages: 253 - 273

10. Lacidipine

    • C. Rhoda Lee
    • Harriet M. Bryson

    Drug Evaluation 11 December 2012 Pages: 274 - 296

11. Roxithromycin

    • Anthony Markham
    • Diana Faulds

    Drug Evaluation 11 December 2012 Pages: 297 - 326

12. Erratum to Long- versus short-acting β2-agonists: implications for drug therapy

    • L-P. Boulet
    • N. von Rosenstiel
    • D. Adam

    Erratum 11 December 2012 Pages: 326 - 326

13. Erratum to Quinolone antibacterials; an update of their pharmacology and therapeutic use

    • N. von Rosenstiel
    • D. Adam

    Erratum 11 December 2012 Pages: 326 - 326

14. Erratum to Gonadotrophin-releasing hormone agonsists; a guide to use and selection

    • M. Filicori

    Erratum 11 December 2012 Pages: 326 - 326